{"schema_version":"alpha-company-profile-public-v2","slug":"ultragenyx-pharmaceutical-inc","canonical_url":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc","published_on":"2026-09-16T04:46:00.818683+00:00","last_reviewed_on":"2026-09-16T04:46:00.818683+00:00","identity":{"legal_name":"Ultragenyx Pharmaceutical Inc.","display_name":"Ultragenyx Pharmaceutical Inc.","headline":"Canonical company identity and public leadership record.","description":"Alpha's canonical identity and public leadership record for Ultragenyx Pharmaceutical Inc..","ten_second_view":"This Company Profile publishes only Alpha's canonical identity and evidence-backed public leadership records. Unavailable fields are not inferred.","legal_form":"Not publicly asserted","incorporation":"Not publicly asserted","headquarters":"US","headquarters_address":{"locality":"Not publicly asserted","region":null,"country":"US"},"operating_presence":["US"],"website":"","cik":"0001515673","logo":"https://cdn.brandfetch.io/ticker/rare/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","logo_source":"brandfetch","profile_mark":{"src":"https://cdn.brandfetch.io/ticker/rare/theme/dark/fallback/404/type/logo?c=1idgAB6rG5KFT5I7q5w","alt":"Ultragenyx Pharmaceutical Inc. logo","width":256,"height":256,"source":"brandfetch"}},"entity_status":{"ownership_type":"unknown","listing_status":"listed","label":"Public listing published","explanation":"The canonical public record includes at least one active security listing.","source_id":"alpha-canonical-company-record","reviewed_on":"2026-09-16T04:46:00.818683+00:00"},"security_listings":[{"ticker":"RARE","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true,"source_id":"alpha-canonical-company-record"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market data is not published in this Company Profile."},"profile_tags":["Canonical identity","Public leadership"],"trust_summary":"Canonical identity published; broader company intelligence is not asserted.","facts":[{"label":"Legal name","value":"Ultragenyx Pharmaceutical Inc.","source_id":"alpha-canonical-company-record"},{"label":"Country","value":"US","source_id":"alpha-canonical-company-record"}],"operating_model":{"eyebrow":"Operating record","title":"Published operating structure","units":[]},"governance":{"summary":"Only current, confirmed leadership roles with public evidence are included in the canonical projection.","boundary":"Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","disclosures":[]},"alpha_opinion":{"status":"Not published","label":"No Alpha opinion published","explanation":"This identity record is not an Alpha rating, score, or investment opinion."},"report":{"status":"Not published","label":"No governed report published","explanation":"No governed company report is attached to this profile.","href":null},"actions":[],"related_records":[],"evidence":[{"id":"alpha-canonical-company-record","label":"Alpha canonical company public projection","href":"/api/public/companies/ultragenyx-pharmaceutical-inc","source_type":"canonical_identity","supports":["Company identity","Published leadership","Entity status boundary"],"status":"published","reviewed_on":"2026-09-16T04:46:00.818683+00:00"}],"permissions":[{"label":"Public retrieval","allowed":true},{"label":"Agent retrieval","allowed":true},{"label":"Redistribution","allowed":false},{"label":"Model training","allowed":false},{"label":"Relationship pathfinding","allowed":false},{"label":"Direct contact","allowed":false}],"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":22,"under_review_claim_count":1,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":22,"corroborated_claims":0,"sources":3,"distinct_sources":2,"role_claims":0,"last_reviewed_at":"2026-09-16T04:46:00.818683+00:00","observed_at":"2026-09-16T04:46:00.818683+00:00","freshness_days":0}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"company","slug":"ultragenyx-pharmaceutical-inc","canonical_url":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc"},"publication":{"published_at":"2026-09-16T04:46:00.818683+00:00","last_reviewed_at":"2026-09-16T04:46:00.818683+00:00","as_of":"2026-09-16T04:46:00.818683+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/companies/ultragenyx-pharmaceutical-inc","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}},"canonical_profile":{"schema_version":"alpha-company-profile-public-v1","slug":"ultragenyx-pharmaceutical-inc","canonical_url":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc","as_of":"2026-09-16T04:46:00.818683+00:00","last_reviewed_at":"2026-09-16T04:46:00.818683+00:00","identity":{"legal_name":"Ultragenyx Pharmaceutical Inc.","display_name":"Ultragenyx Pharmaceutical Inc.","description":null,"jurisdiction":null,"country":"US","sector":null,"industry":null,"website":null,"website_provenance":null,"logo_url":null,"logo_media":null,"status":"active","cik":"0001515673","entity_subtype":null,"legal_entity_status":null},"security_listings":[{"mic":"XNAS","ticker":"RARE","currency":null,"exchange":"NASDAQ","sort_key":0,"valid_to":null,"confidence":0.95,"is_primary":true,"listing_id":"fe6b2797-e184-4167-8696-1a42ef558451","source_url":"https://www.sec.gov/files/company_tickers_exchange.json","valid_from":null,"observed_at":"2026-07-11T00:28:32+00:00","source_name":"sec_company_tickers_exchange","source_tier":1,"exchange_name":"NASDAQ","security_type":"equity","listing_status":"active","last_checked_at":"2026-09-02T01:48:40.989053+00:00"}],"market_data":{"availability":"unavailable","endpoint":null,"source_label":null,"explanation":"Market observations are unpublished. Listing identity remains available from the governed source set."},"index_memberships":[],"index_membership_history":[],"index_membership_contract":{"schema_version":"alpha-index-membership-public-v1","as_of_date":"2026-09-17","tracked_universe_complete":false,"permissions":{"public_retrieval":true,"agent_retrieval":false,"redistribution":false,"model_training":false},"limitations":["Only source-backed memberships with an explicit public redistribution basis are returned.","Absence from Alpha tracked indices does not establish absence from every market index.","Provider announcements and effective membership are represented as distinct states.","Alpha AI 100 is not published as a current public index membership."]},"leadership":{"board":[{"person_slug":"daniel-g-welch-rare","display_name":"Daniel G. Welch","role_category":"director","title":"Independent Chairman of the Board","committee":null,"is_board_chair":true,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null},{"person_slug":"amrit-ray-rare","display_name":"Amrit Ray","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2022-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lrare2026_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_proxy","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-02T01:57:54.019734+00:00"},"headshot_url":null},{"person_slug":"amrit-ray-m-d","display_name":"Amrit Ray, M.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null},{"person_slug":"corsee-d-sanders-rare","display_name":"Corsee D. Sanders","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2021-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lrare2026_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_proxy","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-02T01:57:54.019734+00:00"},"headshot_url":null},{"person_slug":"corsee-d-sanders-ph-d","display_name":"Corsee D. Sanders, Ph.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null},{"person_slug":"deborah-dunsire-rare","display_name":"Deborah Dunsire","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2017-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lrare2026_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_proxy","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-02T01:57:54.019734+00:00"},"headshot_url":null},{"person_slug":"deborah-dunsire-m-d","display_name":"Deborah Dunsire, M.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":"https://qzvwmfoixeflcbvpqboy.supabase.co/storage/v1/object/public/director-photos/directors/06a3a38f-ea34-4a1b-8a39-4ae59601d1db.jpg"},{"person_slug":"emil-d-kakkis-m-d-ph-d","display_name":"Emil D. Kakkis, M.D., Ph.D.","role_category":"director","title":"President, Chief Executive Officer and Director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null},{"person_slug":"matthew-k-fust-rare","display_name":"Matthew K. Fust","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2014-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lrare2026_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_proxy","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-02T01:57:54.019734+00:00"},"headshot_url":null},{"person_slug":"michael-narachi-rare","display_name":"Michael Narachi","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2015-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lrare2026_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_proxy","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-02T01:57:54.019734+00:00"},"headshot_url":null},{"person_slug":"shehnaaz-suliman-rare","display_name":"Shehnaaz Suliman","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2019-01-01","end_date":null,"verification_status":"confirmed","confidence":0.88,"evidence":{"document_title":"DEF 14A lrare2026_def14a.htm","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_proxy","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-02T01:57:54.019734+00:00"},"headshot_url":null},{"person_slug":"shehnaaz-suliman-m-d","display_name":"Shehnaaz Suliman, M.D.","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null}],"executives":[{"person_slug":"dennis-huang","display_name":"Dennis Huang","role_category":"executive","title":"Chief Technical Operations Officer and Gene Therapy and Executive Vice President","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null},{"person_slug":"emil-d-kakkis-m-d-ph-d","display_name":"Emil D. Kakkis, M.D., Ph.D.","role_category":"executive","title":"President and Chief Executive Officer","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null},{"person_slug":"eric-crombez-m-d","display_name":"Eric Crombez, M.D.","role_category":"executive","title":"Chief Medical Officer and Executive Vice President","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null},{"person_slug":"erik-harris","display_name":"Erik Harris","role_category":"executive","title":"Chief Commercial Officer and Executive Vice President","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null},{"person_slug":"howard-horn","display_name":"Howard Horn","role_category":"executive","title":"Chief Financial Officer, Corporate Strategy and Executive Vice President","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null},{"person_slug":"john-r-pinion-ii","display_name":"John R. Pinion II","role_category":"executive","title":"Chief Quality Officer and Executive Vice President of Translational Sciences","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null},{"person_slug":"karah-parschauer","display_name":"Karah Parschauer","role_category":"executive","title":"Chief Legal Officer & Corporate Affairs and Executive Vice President","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null,"verification_status":"confirmed","confidence":0.95,"evidence":{"document_title":"SEC DEF 14A 0001308179-26-000174","source_url":"https://www.sec.gov/Archives/edgar/data/1515673/000130817926000174/lrare2026_def14a.htm","source_type":"sec_def_14a","published_at":"2026-03-27T00:00:00+00:00","effective_date":"2026-03-27","last_checked_at":"2026-09-12T18:07:23.013453+00:00"},"headshot_url":null}],"coverage":{"schema_version":"alpha-leadership-coverage-v1","board_roster_scope":"def_14a_current_directors","executive_roster_scope":"disclosed_officers_only","neo_set_status":"NOT_ASSERTED","board_roster_complete":false,"neo_set_complete":false,"notes":["Empty executives is NOT_ASSERTED, not a complete named-executive-officer set.","Form 4 occupancy is not a DEF 14A board.","Unconfirmed current sec_proxy DEF 14A directors may project. Confirmed is not required.","Unconfirmed current executives with first-party issuer evidence (source_url + effective date) may project.","Company-page directors do not require people.public_profile_enabled.","Completeness compares the latest first-party roster with the public projection; a source older than 180 days is STALE.","Do not remap HONA to HON 0000773840. Do not merge XOM 0000034088 with 0002115436.","Person match is projection-only. Name-only Person merges are forbidden."],"completeness":{"reasons":["NO_LEADERSHIP_SOURCE"],"board_completeness":"NOT_REVIEWED","completeness_schema":"alpha-leadership-completeness-v1","executive_team_completeness":"NOT_REVIEWED"},"parser_bleed_excluded":true,"former_titles_excluded":true,"identity_merge_forbidden":true,"form4_occupancy_is_not_board":true}},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."],"structured_data":{"@context":["https://schema.org",{"alpha":"https://alpha.ac/ns/","indexMembership":"alpha:indexMembership","indexProvider":"alpha:indexProvider","indexMembershipStatus":"alpha:indexMembershipStatus","indexEffectiveDate":"alpha:indexEffectiveDate","indexAnnouncementDate":"alpha:indexAnnouncementDate","indexRemovalDate":"alpha:indexRemovalDate","lastVerifiedAt":"alpha:lastVerifiedAt","verificationStatus":"alpha:verificationStatus","evidence":"alpha:evidence"}],"@type":"ProfilePage","@id":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc#profile","url":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc","dateModified":"2026-09-16T04:46:00.818683+00:00","mainEntity":{"@type":"Organization","@id":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc#organization","legalName":"Ultragenyx Pharmaceutical Inc.","name":"Ultragenyx Pharmaceutical Inc.","url":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc","addressCountry":"US","indexMembership":[],"member":[{"@type":"OrganizationRole","roleName":"Independent Chairman of the Board","member":{"@type":"Person","name":"Daniel G. Welch","url":"https://registry.alpha.ac/people/daniel-g-welch-rare"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2022-01-01","member":{"@type":"Person","name":"Amrit Ray","url":"https://registry.alpha.ac/people/amrit-ray-rare"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Amrit Ray, M.D.","url":"https://registry.alpha.ac/people/amrit-ray-m-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2021-01-01","member":{"@type":"Person","name":"Corsee D. Sanders","url":"https://registry.alpha.ac/people/corsee-d-sanders-rare"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Corsee D. Sanders, Ph.D.","url":"https://registry.alpha.ac/people/corsee-d-sanders-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2017-01-01","member":{"@type":"Person","name":"Deborah Dunsire","url":"https://registry.alpha.ac/people/deborah-dunsire-rare"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Deborah Dunsire, M.D.","url":"https://registry.alpha.ac/people/deborah-dunsire-m-d"}},{"@type":"OrganizationRole","roleName":"President, Chief Executive Officer and Director","member":{"@type":"Person","name":"Emil D. Kakkis, M.D., Ph.D.","url":"https://registry.alpha.ac/people/emil-d-kakkis-m-d-ph-d"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2014-01-01","member":{"@type":"Person","name":"Matthew K. Fust","url":"https://registry.alpha.ac/people/matthew-k-fust-rare"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2015-01-01","member":{"@type":"Person","name":"Michael Narachi","url":"https://registry.alpha.ac/people/michael-narachi-rare"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2019-01-01","member":{"@type":"Person","name":"Shehnaaz Suliman","url":"https://registry.alpha.ac/people/shehnaaz-suliman-rare"}},{"@type":"OrganizationRole","roleName":"Director","member":{"@type":"Person","name":"Shehnaaz Suliman, M.D.","url":"https://registry.alpha.ac/people/shehnaaz-suliman-m-d"}},{"@type":"OrganizationRole","roleName":"Chief Technical Operations Officer and Gene Therapy and Executive Vice President","member":{"@type":"Person","name":"Dennis Huang","url":"https://registry.alpha.ac/people/dennis-huang"}},{"@type":"OrganizationRole","roleName":"President and Chief Executive Officer","member":{"@type":"Person","name":"Emil D. Kakkis, M.D., Ph.D.","url":"https://registry.alpha.ac/people/emil-d-kakkis-m-d-ph-d"}},{"@type":"OrganizationRole","roleName":"Chief Medical Officer and Executive Vice President","member":{"@type":"Person","name":"Eric Crombez, M.D.","url":"https://registry.alpha.ac/people/eric-crombez-m-d"}},{"@type":"OrganizationRole","roleName":"Chief Commercial Officer and Executive Vice President","member":{"@type":"Person","name":"Erik Harris","url":"https://registry.alpha.ac/people/erik-harris"}},{"@type":"OrganizationRole","roleName":"Chief Financial Officer, Corporate Strategy and Executive Vice President","member":{"@type":"Person","name":"Howard Horn","url":"https://registry.alpha.ac/people/howard-horn"}},{"@type":"OrganizationRole","roleName":"Chief Quality Officer and Executive Vice President of Translational Sciences","member":{"@type":"Person","name":"John R. Pinion II","url":"https://registry.alpha.ac/people/john-r-pinion-ii"}},{"@type":"OrganizationRole","roleName":"Chief Legal Officer & Corporate Affairs and Executive Vice President","member":{"@type":"Person","name":"Karah Parschauer","url":"https://registry.alpha.ac/people/karah-parschauer"}}]},"mainEntityOfPage":"https://registry.alpha.ac/companies/ultragenyx-pharmaceutical-inc"},"financials":{"kind":"financials","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"},"ownership":{"kind":"ownership","records":[],"limitation":"Only evidence-backed canonical_assertions already stored for this company. Empty records mean none are stored. Missing values are never invented. 13F and N-PX are not beneficial ownership and are never projected here.","source_table":"canonical_assertions","source_evidence_table":"canonical_source_records"}},"canonical_source":"aegis_canonical"}